小儿肺炎的治疗中采用盐酸氨溴索加盐酸丙卡特罗的临床疗效

Clinical Effect of Ambroxol Hydrochloride Plus Procatrol Hydrochloride in the Treatment of Pediatric Pneumonia

目的探究小儿肺炎的治疗中采用盐酸氨溴索加盐酸丙卡特罗的临床疗效。方法特选取2018年6月至2019年6月于我院儿科接受治疗的680例肺炎患儿作为本次研究的实验对象,根据随机数字表法进行有效分组,均分为对照组和观察组,每组各340例,其中对照组应用基础治疗,观察组则使用盐酸氨溴索加盐酸丙卡特罗进行治疗,比较两组患儿通过不同方式治疗后的临床表现以及血清水平指标。结果通过有效治疗之后观察组患儿在咳嗽、喘息、发热以及肺部啰音等临床症状的消退时长均少于对照组患儿;并且观察组患儿在CRP、TNF-α、NO、SOD以及MDA等血清指标中也明显优于对照组患儿,P<0.05,差异具有统计学意义。结论临床治疗小儿肺炎的过程中应用盐酸氨溴索加盐酸丙卡特罗进行治疗,临床疗效极为显著,能够快速缓解患儿临床表现,应当在临床之中大力推广并应用。

Objective To explore the clinical efficacy of ambroxol hydrochloride plus procaterol hydrochloride in the treatment of infantile pneumonia.Methods A total of 680 children with pneumonia who were treated in pediatrics department of our hospital from June 2018 to June 2019 were selected as the subjects of this study.According to the random number table method,they were divided into two groups:control group and observation group,340 children in each group.The control group was treated with basic treatment and the observation group was treated with basic treatment.The children were treated with ambroxol hydrochloride plus procaterol hydrochloride.The clinical manifestations and serum levels of the two groups were compared after different treatment.Results After effective treatment,the clinical symptoms of cough,wheezing,fever and lung rale in the observation group were less than those in the control group,and the serum indexes of CRP,TNF-a,NO,SOD and MDA in the observation group were also significantly better than those in the control group,P<0.05,the difference is statistically significant.Conclusion The clinical effect of ambroxol hydrochloride plus procaterol hydrochloride in the treatment of pediatric pneumonia is remarkable.It can quickly relieve the clinical manifestations of children.It should be popularized and applied in clinic.